A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia

Stopped The study was terminated prior to completion to focus on the development of a controlled release formulation.

Conditions

• Obesity
• Hyperlipidemia
• Hypertriglyceridemia

Interventions

• DRUG: topiramate

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.